Amalgamated Bank Dice Therapeutics, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$25.86 - $46.71 $42,720 - $77,164	1,652 Added 44.34%	5,378 $249,000
Q1 2023 May 02, 2023	SELL	$26.05 - $32.31 $24,148 - $29,951	-927 Reduced 19.92%	3,726 $107,000
Q4 2022 Feb 10, 2023	BUY	$19.77 - $42.23 $20,896 - $44,637	1,057 Added 29.39%	4,653 $145,000
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $20,668 - $34,630	1,567 Added 77.23%	3,596 $56,000
Q1 2022 Jun 30, 2022	BUY	$14.54 - $25.02 $29,501 - $50,765	2,029 New	2,029 $39,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.